Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma? - Wikidata - wikimedia - TriplyDB

Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma?

Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma?

http://www.wikidata.org/entity/Q38129954

about

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma Nanoparticulate drug delivery platforms for advancing bone infection therapies.Biology of Bone Sarcomas and New Therapeutic Developments.

P2860

Q26771376-71E30F21-F6F9-4108-81A8-7AA75B96A5AB Q35373671-31780DE0-05BB-4FB3-A758-137861EC3679 Q48120956-B9AE9BCD-B548-4A62-AFE1-6491304634A1

P2860

Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma?

http://www.wikidata.org/entity/Q38129954

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma?

@en

type

label

Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma?

@en

prefLabel

Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma?

@en

P1433

Q38129954-7CDE00A1-7955-4356-AD8C-8B2915F2366E

P1476

Q38129954-8319FFB6-F1C3-480B-9C85-0FEE601C3A6A

P2093

Q38129954-61A74FDA-33E2-4314-B29D-88B0A2DD8CD8

Q38129954-77657809-B8CA-4659-BD94-7F13B374400D

Q38129954-BE3699F8-CB5E-4CB1-8F2D-CA252F417DB4

Q38129954-DAC8D167-3996-42A8-9190-2FBAB129969F

Q38129954-DD938534-0C77-464F-BA42-6F7F66C1B326

Q38129954-E7771B02-F11B-4BF5-9F83-93651FC4AF71

P2860

Q38129954-0134E3F6-2CB1-419C-911B-409E4A7D74A5

Q38129954-05B48E2D-B95C-4119-8512-CBC752680EC3

Q38129954-05D6A527-57F1-4EC3-89DD-9F44C427334E

Q38129954-07CB45F2-7BA7-41AF-8FC9-CF5A6133F542

Q38129954-0CF4532A-F4E1-43C0-AA7E-5268BF723288

Q38129954-1811620A-0B3F-4C6D-AD84-1B947196F3A5

Q38129954-1D0B1524-1ABC-4687-A78D-B23DD74AF73E

Q38129954-1D403809-432C-4391-B6FE-B72F3C3C4847

Q38129954-1E20C2D2-79AB-4895-BB34-1E2C564702A7

Q38129954-1FECB308-2607-4404-8005-716C23CE568E

P304

Q38129954-D995FDCD-5A4A-4AC1-81B7-2F3801C48DBC

P31

Q38129954-085E3648-0154-47D5-AD17-2D2D930BBFE0

P356

Q38129954-3D39D33C-B995-45E1-867C-06BBE8E5E6BB

P407

Q38129954-E6173212-129E-4315-B5CA-FC6EB8F5CD4E

P433

Q38129954-5B408E01-1070-4038-B212-9A2F5BA43A96

P478

Q38129954-0B78D2D6-C963-4C43-BA1C-EDD58A51BD39

P50

Q38129954-7AC84CB0-100E-41CD-BE20-56DCAF35E580

P577

Q38129954-316FCB3F-DB22-45FC-8174-496F99793156

P698

Q38129954-73C390BF-6547-440F-8EAA-60227D8BD137

P356

14728214.2013.823948

P1433

Expert Opinion on Emerging Drugs

P1476

Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma?

@en

P2093

Francoise Redini

http://www.w3.org/2001/XMLSchema#string

Gaëlle Picarda

http://www.w3.org/2001/XMLSchema#string

Guillaume A Odri

http://www.w3.org/2001/XMLSchema#string

Marie-Françoise Heymann

http://www.w3.org/2001/XMLSchema#string

Nadege Corradini

http://www.w3.org/2001/XMLSchema#string

Nathalie Gaspar

http://www.w3.org/2001/XMLSchema#string

P2860

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma

Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study.

Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group

Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor

ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathways.

Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro.

Mesenchymal stem cell features of Ewing tumors.

P304

339-352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.2013.823948

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Heymann

P577

2013-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23957761

http://www.w3.org/2001/XMLSchema#string